Could a Simple Blood Test Detect Cancer at an Early—and More Treatable—Stage? The Technology Exists—and FDA Approval May Not Be Far Off
10th April 2023
Like cancer vaccines, cancer blood panels aren’t some far-flung, futuristic goal. Multi-cancer early detection tests, known as MCEDs, are a thing—right now. Today. Google the phrase and you’ll find multiple products available for purchase. You can have one at your door in mere days.
It’s a concept that has promise, experts say. “The technology is advancing truly at a rapid pace,” Karen Knudsen, CEO of the American Cancer Society, tells Fortune. “I think all of us in the oncology world think that the next frontier is liquid biopsy”—another term for MCED.